Nifty

:

25044.35

Sensex

:

82055.11

72.45 (0.29%)
158.32 (0.19%)

Login

Nifty
Sensex

:
:

25044.35
82055.11

72.45 (0.29%)
158.32 (0.19%)

Bajaj Healthcare Ltd.

Pharmaceuticals & Drugs - API

Rating :

64/99

BSE: 539872 | NSE: BAJAJHCARE

Watchlist

NSE BSE

528.60

24-Jun-2025

Open
High
Low
Previous Close

533
542
525.3
524.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

87860
46880504.5
745
312

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

1,669.33
38.88
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,887.51
0.19%
3.58

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.15
2.92
-11.37

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.23
9.60
-8.44

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-

P:E (Median)

8 Years
5 Years
3 Years

15.97
14.24
15.92

P:BV (Average)

8 Years
5 Years
3 Years

3.45
3.46
3.16

EV:EBITDA (Average)

8 Years
5 Years
3 Years

11.20
12.11
14.45

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 154.47 133.90 15.36% 122.79 108.57 13.10% 133.09 101.21 31.50% 132.25 129.74 1.93%
Expenses 142.72 117.87 21.08% 101.15 89.04 13.60% 108.57 82.26 31.98% 107.74 107.99 -0.23%
EBITDA 11.76 16.03 -26.64% 21.64 19.54 10.75% 24.52 18.95 29.39% 24.50 21.74 12.70%
EBIDTM 7.61% 11.97% 17.62% 17.99% 18.43% 18.72% 18.53% 16.76%
Other Income 13.57 6.45 110.39% 2.37 0.80 196.25% 2.61 1.22 113.93% 0.85 0.22 286.36%
Interest 6.08 6.01 1.16% 5.51 6.65 -17.14% 7.88 8.26 -4.60% 8.44 8.75 -3.54%
Depreciation 7.53 7.30 3.15% 6.85 7.35 -6.80% 6.81 6.66 2.25% 6.73 6.31 6.66%
PBT 11.72 -35.15 - 11.65 6.33 84.04% 12.45 5.24 137.60% 10.18 6.90 47.54%
Tax 0.13 -3.15 - -3.31 0.80 - 4.10 0.12 3,316.67% 2.16 -0.12 -
PAT 11.59 -32.00 - 14.97 5.52 171.20% 8.34 5.12 62.89% 8.03 7.03 14.22%
PATM 7.50% -23.90% 12.19% 5.09% 6.27% 5.06% 6.07% 5.42%
EPS 3.67 -10.13 - 4.74 1.75 170.86% 2.64 1.62 62.96% 2.54 2.22 14.41%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 542.60 473.42 645.80 679.89 656.98 410.01 325.02 289.51 207.24 200.23 197.25 Net Sales Growth 14.61% -26.69% -5.01% 3.49% 60.24% 26.15% 12.27% 39.70% 3.50% 1.51% Cost Of Goods Sold 286.44 254.77 382.78 406.14 377.89 263.23 196.87 177.68 111.23 105.65 110.94 Gross Profit 256.16 218.65 263.01 273.75 279.09 146.78 128.15 111.83 96.01 94.57 86.31 GP Margin 47.21% 46.19% 40.73% 40.26% 42.48% 35.80% 39.43% 38.63% 46.33% 47.23% 43.76% Total Expenditure 460.18 397.08 534.32 561.23 520.62 361.73 282.09 250.08 176.40 170.18 168.43 Power & Fuel Cost - 31.47 37.69 31.83 24.96 24.24 21.83 19.81 16.79 14.12 13.42 % Of Sales - 6.65% 5.84% 4.68% 3.80% 5.91% 6.72% 6.84% 8.10% 7.05% 6.80% Employee Cost - 43.85 42.32 41.11 34.55 28.18 24.62 21.65 19.57 16.93 14.45 % Of Sales - 9.26% 6.55% 6.05% 5.26% 6.87% 7.57% 7.48% 9.44% 8.46% 7.33% Manufacturing Exp. - 38.89 34.11 59.68 64.02 28.56 25.07 21.53 19.89 23.16 22.73 % Of Sales - 8.21% 5.28% 8.78% 9.74% 6.97% 7.71% 7.44% 9.60% 11.57% 11.52% General & Admin Exp. - 10.54 11.08 12.74 11.03 7.95 6.64 5.06 5.76 5.87 5.03 % Of Sales - 2.23% 1.72% 1.87% 1.68% 1.94% 2.04% 1.75% 2.78% 2.93% 2.55% Selling & Distn. Exp. - 14.57 19.09 3.91 4.17 1.28 1.77 1.64 1.26 1.17 1.24 % Of Sales - 3.08% 2.96% 0.58% 0.63% 0.31% 0.54% 0.57% 0.61% 0.58% 0.63% Miscellaneous Exp. - 2.99 7.25 5.81 4.00 8.28 5.29 2.70 1.90 3.28 1.24 % Of Sales - 0.63% 1.12% 0.85% 0.61% 2.02% 1.63% 0.93% 0.92% 1.64% 0.31% EBITDA 82.42 76.34 111.48 118.66 136.36 48.28 42.93 39.43 30.84 30.05 28.82 EBITDA Margin 15.19% 16.13% 17.26% 17.45% 20.76% 11.78% 13.21% 13.62% 14.88% 15.01% 14.61% Other Income 19.40 8.69 1.59 1.44 6.91 6.53 0.97 2.07 2.39 0.38 0.07 Interest 27.91 29.75 17.68 12.78 8.34 6.63 8.32 7.73 8.20 7.64 8.02 Depreciation 27.92 27.62 17.21 17.64 16.12 12.12 11.41 11.08 11.35 9.29 8.86 PBT 46.00 27.65 78.18 89.68 118.82 36.06 24.17 22.68 13.69 13.50 12.02 Tax 3.08 -2.35 14.65 18.30 35.71 10.82 7.86 7.50 5.87 5.30 4.50 Tax Rate 6.70% 14.09% 18.74% 20.41% 30.05% 30.01% 32.52% 33.07% 42.88% 39.26% 37.44% PAT 42.93 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 8.20 7.51 PAT before Minority Interest 42.93 -14.33 63.53 71.39 83.11 25.24 16.31 15.19 7.82 8.20 7.51 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 7.91% -3.03% 9.84% 10.50% 12.65% 6.16% 5.02% 5.25% 3.77% 4.10% 3.81% PAT Growth 399.58% - -11.01% -14.10% 229.28% 54.75% 7.37% 94.25% -4.63% 9.19% EPS 13.59 -4.53 20.10 22.59 26.30 7.99 5.16 4.81 2.47 2.59 2.38

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 278.36 367.69 328.49 258.41 177.93 129.11 113.61 99.00 88.63 81.93 Share Capital 13.80 13.80 13.80 13.80 13.80 6.90 6.90 6.90 6.75 3.75 Total Reserves 264.56 353.89 314.69 244.61 164.13 122.21 106.71 92.10 81.88 78.18 Non-Current Liabilities 23.43 96.37 70.54 84.65 27.40 20.41 23.45 27.69 32.26 22.24 Secured Loans 38.58 93.66 66.31 79.71 22.97 16.19 19.80 24.41 27.45 17.55 Unsecured Loans 0.00 0.00 0.00 0.00 0.60 1.20 1.68 2.43 4.00 4.67 Long Term Provisions 6.14 1.45 2.67 2.78 2.08 1.42 0.77 0.00 0.00 0.00 Current Liabilities 402.11 435.23 322.07 182.57 137.61 117.34 131.07 92.55 88.13 84.54 Trade Payables 89.43 84.75 104.92 68.95 57.48 29.98 43.38 18.85 16.17 22.75 Other Current Liabilities 51.07 47.55 31.44 24.98 21.18 25.62 25.93 20.02 20.06 18.91 Short Term Borrowings 261.48 289.42 176.20 88.47 58.43 54.89 54.52 39.16 42.29 37.42 Short Term Provisions 0.12 13.51 9.51 0.18 0.52 6.84 7.25 14.52 9.60 5.45 Total Liabilities 703.90 899.29 721.10 525.63 342.94 266.86 268.13 219.24 209.02 188.71 Net Block 252.75 365.69 269.74 208.13 162.24 128.50 126.62 127.93 129.56 108.50 Gross Block 422.98 525.01 401.73 329.25 267.83 222.23 209.65 199.88 191.39 161.81 Accumulated Depreciation 170.23 159.32 131.99 121.13 105.59 93.74 83.03 71.95 61.83 53.31 Non Current Assets 263.22 397.26 322.79 267.30 174.53 129.68 128.59 128.16 131.02 109.68 Capital Work in Progress 6.62 21.73 51.98 57.05 5.45 1.18 1.97 0.23 1.46 1.17 Non Current Investment 0.00 0.00 0.00 0.00 5.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Other Non Current Assets 2.70 9.84 1.07 2.12 1.84 0.00 0.00 0.00 0.00 0.00 Current Assets 404.54 502.04 398.31 258.33 168.42 137.17 139.55 91.08 78.00 79.03 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 144.04 208.79 159.26 97.11 39.28 30.05 33.66 16.76 19.64 18.08 Sundry Debtors 180.24 194.17 184.51 98.88 98.48 78.13 80.38 52.69 42.95 51.52 Cash & Bank 2.93 19.23 1.98 14.24 4.16 7.86 8.29 0.84 0.36 0.87 Other Current Assets 77.33 35.58 37.59 32.00 26.50 21.13 17.21 20.79 15.04 8.56 Short Term Loans & Adv. 30.10 44.27 14.97 16.10 13.13 18.79 14.98 18.19 12.84 6.73 Net Current Assets 2.43 66.80 76.24 75.76 30.80 19.83 8.47 -1.47 -10.13 -5.51 Total Assets 667.76 899.30 721.10 525.63 342.95 266.85 268.14 219.24 209.02 188.71

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 92.29 -22.19 0.69 43.56 20.57 25.17 16.61 22.12 25.14 27.89 PBT -103.87 58.22 89.68 118.82 36.06 24.17 22.68 13.69 13.50 12.02 Adjustment 170.44 55.89 31.47 24.48 15.54 20.06 18.77 19.32 16.83 16.70 Changes in Working Capital 38.51 -124.76 -110.84 -64.09 -21.91 -6.04 -18.88 -5.81 -0.31 -0.08 Cash after chg. in Working capital 105.08 -10.66 10.32 79.21 29.70 38.19 22.58 27.20 30.03 28.63 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -12.79 -11.54 -9.63 -35.65 -9.12 -13.02 -5.96 -5.08 -4.89 -0.74 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -11.24 -93.43 -74.80 -108.93 -27.56 -13.03 -11.64 -8.45 -30.67 -16.71 Net Fixed Assets 117.14 -93.03 -67.41 -113.02 -49.87 -11.79 -11.51 -7.26 -29.87 -59.73 Net Investments 0.00 0.00 0.00 5.00 -5.00 0.00 0.00 0.00 0.00 0.00 Others -128.38 -0.40 -7.39 -0.91 27.31 -1.24 -0.13 -1.19 -0.80 43.02 Cash from Financing Activity -96.60 131.37 61.85 75.46 3.28 -12.57 2.47 -13.20 5.08 -11.36 Net Cash Inflow / Outflow -15.55 15.75 -12.27 10.08 -3.70 -0.42 7.45 0.47 -0.44 -0.18 Opening Cash & Equivalents 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.36 0.87 0.99 Closing Cash & Equivalent 2.17 17.72 1.98 14.24 4.16 7.86 8.29 0.84 0.42 0.81

Financial Ratios

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 100.86 133.23 119.02 93.63 64.47 64.41 52.73 71.74 34.33 27.64 ROA -1.74% 7.84% 11.45% 19.14% 8.28% 6.10% 6.23% 3.65% 4.12% 4.50% ROE -4.44% 18.25% 24.33% 38.09% 18.92% 20.18% 17.68% 10.77% 19.60% 22.38% ROCE 1.88% 14.02% 20.00% 35.91% 19.47% 19.75% 18.25% 14.52% 18.00% 19.16% Fixed Asset Turnover 2.00 2.79 1.86 2.20 1.67 1.71 1.60 1.18 1.26 1.66 Receivable days 72.17 53.51 76.07 54.82 78.61 78.15 74.24 75.67 77.37 88.85 Inventory Days 68.01 52.00 68.82 37.89 30.86 31.41 28.13 28.80 30.89 34.51 Payable days 124.77 90.43 78.13 61.06 43.87 46.86 44.67 35.97 41.39 56.94 Cash Conversion Cycle 15.40 15.08 66.76 31.65 65.59 62.70 57.71 68.50 66.87 66.43 Total Debt/Equity 1.19 1.13 0.78 0.70 0.51 0.91 1.19 0.76 1.75 1.77 Interest Cover 0.44 5.42 8.02 15.25 6.44 3.91 3.93 2.67 2.77 2.50

Top Investors:

vanaja sundar iyer

weststone management consultancy pvt ltd

hdfc mutual fund - hdfc pharma and healthcare fund

Annual Reports:

News Update:

Bajaj Healthcare acquires Genrx Pharmaceuticals
8th Apr 2025, 11:39 AM

The acquisition, valued at Rs 10.85 crore through a cash consideration, involves 100% control of the target entity
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback